Letter

DNA methods should be used to detect Chlamydia trachomatis

BMJ 1998; 317 doi: 10.1136/bmj.317.7171.1525 (Published 28 November 1998)
Cite this as: BMJ 1998;317:1525.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Taylor-Robinson,
  2. Angela J Robinson
  1. Department of Genitourinary Medicine and Communicable Diseases, Imperial College School of Medicine at St Mary's, London W2 1NY
  2. Department of Genitourinary Medicine, Mortimer Market Centre, London WC1E 6AU

    EDITOR—We agree with the comments1 on Boag and Kelly's editorial2 about the recommendations made by the chief medical officer's expert advisory group on Chlamydia trachomatis. We wish to raise another issue.

    The laboratories associated with the genitourinary medicine clinics in the two pilot projects evaluating the proposed screening will use molecular procedures (ligase chain reaction or polymerase chain reaction) and not the less sensitive tests (enzyme immunoassays) …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular